Aligos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | 11/14/2025 | 468.20 K | $4.59 M | -9.67% | 4.52% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 444.11 K | $4.35 M | 0.00% | 4.29% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 412.00 K | $4.04 M | 0.00% | 3.98% |
| SIO CAPITAL MANAGEMENT, LLC | 11/13/2025 | 335.94 K | $3.29 M | 0.00% | 3.25% |
| READYSTATE ASSET MANAGEMENT LP | 11/07/2025 | 203.11 K | $1.99 M | 48.49% | 1.96% |
| VANGUARD GROUP INC | 11/07/2025 | 171.69 K | $1.68 M | 22.83% | 1.66% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 140.00 K | $1.37 M | 0.00% | 1.35% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 83.06 K | $813.94 K | 0.00% | 0.80% |
| HHLR ADVISORS, LTD. | 11/14/2025 | 76.25 K | $747.22 K | 0.00% | 0.74% |
| LPL FINANCIAL LLC | 11/12/2025 | 55.12 K | $540.18 K | 83.12% | 0.53% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 55.02 K | $539.19 K | 4.71% | 0.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 47.08 K | $461.59 K | 38.28% | 0.45% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 39.00 K | $382.15 K | 222.99% | 0.38% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 30.49 K | $298.83 K | 64.04% | 0.29% |
| UBS GROUP AG | 11/13/2025 | 16.18 K | $158.58 K | 489.94% | 0.16% |
| BLACKROCK, INC. | 11/12/2025 | 13.04 K | $127.79 K | 0.00% | 0.13% |
| MORGAN STANLEY | 11/14/2025 | 11.28 K | $110.58 K | 181.75% | 0.11% |
| CITADEL ADVISORS LLC | 11/14/2025 | 10.31 K | $101.04 K | -32.16% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 10.11 K | $99.05 K | 100.00% | 0.10% |
| NORTHCREST ASSET MANANGEMENT, LLC | 10/29/2025 | 10.00 K | $98.40 K | 100.00% | 0.10% |
| QUEST PARTNERS LLC | 11/03/2025 | 6.77 K | $66.37 K | 13.95% | 0.07% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 3.17 K | $31.07 K | -76.98% | 0.03% |
| GOLDEN STATE WEALTH MANAGEMENT, LLC | 11/03/2025 | 2.67 K | $26.21 K | 0.00% | 0.03% |
| ROYAL BANK OF CANADA | 11/14/2025 | 2.13 K | $21.00 K | 0.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.91 K | $18.76 K | -26.72% | 0.02% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 1.00 K | $9.80 K | 100.00% | 0.01% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/21/2025 | 800 | $7.84 K | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 708 | $6.94 K | 2,623.08% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 457 | $4.48 K | -58.57% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 26 | $255 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 15 | $147 | 100.00% | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 10/14/2025 | 4 | $40 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 3 | $29 | -99.83% | 0.00% |
| FMR LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Aligos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 47 institutional investors and hedge funds held shares of Aligos Therapeutics, Inc.. The most heavily invested institutionals were:
Woodline Partners LP: 468,199
Deep Track Capital, LP: 444,110
Alyeska Investment Group, L.P.: 412,000
Sio Capital Management, LLC: 335,937
READYSTATE ASSET MANAGEMENT LP: 203,113
VANGUARD GROUP INC: 171,689
25.62% of Aligos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.92 M shares in the last 24 months. This purchase volume represents approximately $59.63 M in transactions.